We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Commercializing Protein Tomography Solutions

By Labmedica staff writers
Posted on 20 Mar 2006
Sidec Technologies (Torshmnagatan) and FEI company (Hillsboro) have announced that the two companies will collaborate on the commercialization of protein tomography solutions and software, using Sidec's software and intellectual property and FEI's transmission electron microscopes (TEMs). More...
Based on current practices, protein tomography is estimated to be a U.S.$200 million market with the potential to grow several-fold within a few years.

Protein tomography was developed for studying the molecular nature of disease pathways and for validating preclinical models and investigating the activity of candidate therapeutics. Protein tomography makes it possible to visualize biomolecules in situ, even in a cell membrane. FEI has developed cryo-electron microscopy for the imaging of biologic structures in collaboration with academic groups in Europe and the United States. Sidec is developing protein imaging using cryo-electron microscopy, and has research collaborations with global pharmaceutical companies.

Advanced electron microscopy instrumentation, data acquisition, and reconstruction software that enable the imaging and analysis of individual protein molecules in cells and tissues are being offered by FEI and Sidec. The service is being provided through Sidec, as an on-premises service or through software and other intellectual property license arrangements, combined with a TEM sale.


Related Links:
Sidec
FEI

Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.